Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achaogen Inc (NASDAQ:AKAO)

18.22
Delayed Data
As of Aug 18
 +0.33 / +1.84%
Today’s Change
3.68
Today|||52-Week Range
27.79
+39.94%
Year-to-Date
No recent news for Achaogen Inc.

Today’s Trading

Previous close17.89
Today’s open17.80
Day’s range17.53 - 18.29
Volume910,960
Average volume (3 months)759,431
Market cap$769.5M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-101.34%
Earnings growth (this year)+5.71%
Earnings growth (next 5 years)--
Revenue growth (last year)+60.29%
P/E ratioNM
Price/Sales7.39
Price/Book6.08

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...-0.21-3.12%
CLLSCellectis SA+0.20+0.92%
INSMInsmed Inc+0.08+0.66%
ACRSAclaris Therapeutics...-0.30-1.19%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$41.8M
Annual profit (last year)-$71.2M
Net profit margin-170.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Kenneth J. Hillan
President &
Chief Operating Officer
Blake Wise
Corporate headquarters
South San Francisco, California

Forecasts